OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type i interferon production

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Oh, Ji Eun ^a   Lee, Myeong Sup ^b   Kim, Young Joon ^c   Lee, Heung Kyu ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ANTIVIRUS AGENT; CYTOKINE; INTERFERON; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; OASL1 PROTEIN, MOUSE;

ANIMAL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL MOTION; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DEFICIENCY; HEMATOPOIESIS; HERPES GENITALIS; HERPES SIMPLEX VIRUS 2; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; METABOLISM; MONOCYTE; MUCOSA; PATHOLOGY; VIROLOGY;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, LY; ANTIVIRAL AGENTS; BONE MARROW CELLS; CELL MOVEMENT; CROSS-PRIMING; CYTOKINES; HEMATOPOIESIS; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; IMMUNITY, INNATE; INFLAMMATION; INTERFERON TYPE I; MICE, INBRED C57BL; MONOCYTES; MUCOUS MEMBRANE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84954193004     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19089     Document Type: Article

References (42)

1. Wald, A. & Link, K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 185, 45-52 (2002).
2. Johnston, C., Koelle, D. M. & Wald, A. HSV-2: in pursuit of a vaccine. J. Clin. Invest. 121, 4600-4609 (2011).
3. Gill, N., Deacon, P. M., Lichty, B., Mossman, K. L. & Ashkar, A. A. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. J. Virol. 80, 9943-9950 (2006).
4. Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H. & Schreiber, R. D. How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264 (1998).
5. Katze, M. G., He, Y. P. & Gale, M. Viruses and interferon: A fight for supremacy. Nat. Rev. Immunol. 2, 675-687 (2002).
6. Crouse, J., Kalinke, U. & Oxenius, A. Regulation of antiviral T cell responses by type I interferons. Nat. Rev. Immunol. 15, 231-242 (2015).
7. Kotenko, S. V. et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4, 69-77 (2003).
8. Sheppard, P. et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4, 63-68 (2003).
9. Donnelly, R. P. & Kotenko, S. V. Interferon-Lambda: A New Addition to an Old Family. J. Interferon Cytokine Res. 30, 555-564 (2010).
10. Sommereyns, C., Paul, S., Staeheli, P. & Michiels, T. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Path. 4, e1000017 (2008).
11. Pott, J. et al. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. USA 108, 7944-7949 (2011).
12. Nice, T. J. et al. Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity. Science 347, 269-273 (2015).
13. Ank, N. et al. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J. Immunol. 180, 2474-2485 (2008).
14. Ank, N. et al. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80, 4501-4509 (2006).
15. Lee, M. S., Kim, B., Oh, G. T. & Kim, Y.-J. OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7. Nat. Immunol. 14, 346-355 (2013).
16. Honda, K., Takaoka, A. & Taniguchi, T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349-360 (2006).
17. Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511 (2004).
18. Sato, M. et al. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441, 106-110 (1998).
19. Honda, K. et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434, 772-777 (2005).
20. Lee, M. S., Park, C. H., Jeong, Y. H., Kim, Y. J. & Ha, S. J. Negative Regulation of Type I IFN Expression by OASL1 Permits Chronic Viral Infection and CD8(+) T-Cell Exhaustion. PLoS Path. 9, e1003478 (2013).
21. Shen, H. & Iwasaki, A. A crucial role for plasmacytoid dendritic cells in antiviral protection by CpG ODN-based vaginal microbicide. J. Clin. Invest. 116, 2237-2243 (2006).
22. Lund, J. M., Linehan, M. M., Iijima, N. & Iwasaki, A. Cutting Edge: Plasmacytoid Dendritic Cells Provide Innate Immune Protection against Mucosal Viral Infection In Situ. J. Immunol. 177, 7510-7514 (2006).
23. Swiecki, M., Wang, Y. M., Gilfillan, S. & Colonna, M. Plasmacytoid Dendritic Cells Contribute to Systemic but Not Local Antiviral Responses to HSV Infections. PLoS Path. 9, e1003728 (2013).
24. Le Bon, A. et al. Cross-priming of CD8(+) T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4, 1009-1015 (2003).
25. Vareille, M., Kieninger, E., Edwards, M. R. & Regamey, N. The Airway Epithelium: Soldier in the Fight against Respiratory Viruses. Clin. Microbiol. Rev. 24, 210-229 (2011).
26. Wira, C. R., Grant-Tschudy, K. S. & Crane-Godreau, M. A. Epithelial cells in the female reproductive tract: A central role as sentinels of immune protection. Am. J. Reprod. Immunol. 53, 65-76 (2005).
27. Sato, A. & Iwasaki, A. Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments. Proc. Natl. Acad. Sci. USA 101, 16274-16279 (2004).
28. Prakash, A., Smith, E., Lee, C. K. & Levy, D. E. Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J. Biol. Chem. 280, 18651-18657 (2005).
29. Huber, J. P. & Farrar, J. D. Regulation of effector and memory T-cell functions by type I interferon. Immunology 132, 466-474 (2011).
30. Matikainen, S. et al. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12. Eur. J. Immunol. 31, 2236-2245 (2001).
31. Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: Endogenous activators of dendritic cells. Nat. Med. 5, 1249-1255 (1999).
32. Luft, T. et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161, 1947-1953 (1998).
33. Montoya, M. et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99, 3263-3271 (2002).
34. Scheu, S., Dresing, P. & Locksley, R. M. Visualization of IFN beta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proc. Natl. Acad. Sci. USA 105, 20416-20421 (2008).
35. Lee, H. K. et al. Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J. Exp. Med. 206, 359-370 (2009).
36. Morrison, L. A., Da Costa, X. J. & Knipe, D. M. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge. Virology 243, 178-187 (1998).
37. Zhao, X. et al. Vaginal Submucosal Dendritic Cells, but Not Langerhans Cells, Induce Protective Th1 Responses to Herpes Simplex Virus-2. J. Exp. Med. 197, 153-162 (2003).
38. Wang, R. X. et al. Antiviral Responses in Mouse Embryonic Stem Cells differential development of cellular mechanisms in type i interferon production and response. J. Biol. Chem. 289, 25186-25198 (2014).
39. Pan, Y. et al. Smurf2 negatively modulates RIG-I-dependent antiviral response by targeting VISA/MAVS for ubiquitination and degradation. J. Immunol. 192, 4758-4764 (2014).
40. Ichinohe, T., Lee, H. K., Ogura, Y., Flavell, R. & Iwasaki, A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206, 79-87 (2009).
41. Iijima, N., Mattei, L. M. & Iwasaki, A. Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue. Proc. Natl. Acad. Sci. USA 108, 284-289 (2011).
42. Lee, H. K. et al. In Vivo Requirement for Atg5 in Antigen Presentation by Dendritic Cells. Immunity 32, 227-239 (2010).